Warfarin-induced skin necrosis: a rare but catastrophic complication of warfarin

F. Singh, Kumar A Singh, Gupta A, Rao Asn Warfarin, M. Singh, U. Prashanth, Ashutosh Kumar, R. Singh, A. Gupta, Asn Rao
{"title":"Warfarin-induced skin necrosis: a rare but catastrophic complication of warfarin","authors":"F. Singh, Kumar A Singh, Gupta A, Rao Asn Warfarin, M. Singh, U. Prashanth, Ashutosh Kumar, R. Singh, A. Gupta, Asn Rao","doi":"10.13172/2052-0077-2-4-562","DOIUrl":null,"url":null,"abstract":"Introduction Warfarin-induced skin necrosis is a rare but catastrophic complication of warfarin therapy, ranging in prevalence from 0.01% to 0.1%. This case report discusses a case of warfarininduced skin necrosis. Case report We report the case of an obese, 55-year-old woman who presented with extensive skin necrosis of the left lower limb on the fifth day of warfarin therapy and responded well with early diagnosis and treatment. Discussion Warfarin-induced skin necrosis is the result of a relatively hypercoagulable state produced by warfarin. Warfarin-induced skin necrosis typically occurs in obese, perimenopausal women of around 50 years of age with high loading doses of warfarin. Warfarin-induced skin necrosis typically involves skin and subcutaneous tissue overlying areas with significant adipose tissue, such as the breast, abdomen, thigh or buttocks. It presents within three to six days after beginning therapy. Conclusion Prevention and management of warfarin-induced skin necrosis in a timely manner should be emphasised to prevent permanent tissue damage. A more gradual approach using low initial dose and gradual increase in daily doses is believed to reduce the risk of warfarin-induced skin necrosis. Introduction Warfarin is a very commonly used anticoagulant in medical practice. Warfarin-induced skin necrosis (WISN) is a rare but catastrophic complication of warfarin therapy, ranging in prevalence from 0.01% to 0.1%1,2. Here, we report the case of a 55-year-old woman with WISN. Case report A 55-year-old woman was admitted to the hospital due to pain and swelling of her right leg. Her right lower limb was cold and right leg circumference was 8 cm more that the left one. Her vital parameters were in the normal range. Cardiovascular, respiratory and abdominal examination was normal. The patient had had a right hip fracture 35 days prior to presentation and was under conservative therapy at the time of presentation at our hospital. Colour Doppler ultrasound of the lower limb vessels revealed thrombosis in the right popliteal, superficial, deep and common femoral veins. Parenteral heparin and oral warfarin were started and coagulation tests were performed daily. Warfarin was initiated at a dose of 15 mg on the first day, 10 mg on the second day and 5 mg on the third day. On the third day, the international normalised ratio (INR) was in the normal range and parenteral heparin was discontinued. On the fifth day of warfarin therapy, the patient developed diffused, extremely painful, erythematous skin eruptions in the left lower limb. On the sixth day, the skin began to peel off and the condition progressed to an extensive lesion with severe skin necrosis of the left lower limb (Figure 1). Warfarin was discontinued and intravenous heparin was started. Vitamin K and fresh frozen plasma were also administered. Tests for factor V Leiden, lupus anticoagulant, anticardiolipin and antiphospholipid antibodies were negative. Surgical debridement of the necrotic area was performed and skin grafting was performed later. Finally, the patient was discharged after two months with a good general condition, on therapy with enoxaprin. * Corresponding author Email: dr.mahi1118@gmail.com 1 Department of Surgery, Vardhaman Mahavir Medical College and Safdarjung Hospital, New Delhi 110029, India Figure 1: Warfarin-induced extensive skin necrosis. De rm at ol og y","PeriodicalId":19393,"journal":{"name":"OA Case Reports","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2013-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"OA Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13172/2052-0077-2-4-562","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction Warfarin-induced skin necrosis is a rare but catastrophic complication of warfarin therapy, ranging in prevalence from 0.01% to 0.1%. This case report discusses a case of warfarininduced skin necrosis. Case report We report the case of an obese, 55-year-old woman who presented with extensive skin necrosis of the left lower limb on the fifth day of warfarin therapy and responded well with early diagnosis and treatment. Discussion Warfarin-induced skin necrosis is the result of a relatively hypercoagulable state produced by warfarin. Warfarin-induced skin necrosis typically occurs in obese, perimenopausal women of around 50 years of age with high loading doses of warfarin. Warfarin-induced skin necrosis typically involves skin and subcutaneous tissue overlying areas with significant adipose tissue, such as the breast, abdomen, thigh or buttocks. It presents within three to six days after beginning therapy. Conclusion Prevention and management of warfarin-induced skin necrosis in a timely manner should be emphasised to prevent permanent tissue damage. A more gradual approach using low initial dose and gradual increase in daily doses is believed to reduce the risk of warfarin-induced skin necrosis. Introduction Warfarin is a very commonly used anticoagulant in medical practice. Warfarin-induced skin necrosis (WISN) is a rare but catastrophic complication of warfarin therapy, ranging in prevalence from 0.01% to 0.1%1,2. Here, we report the case of a 55-year-old woman with WISN. Case report A 55-year-old woman was admitted to the hospital due to pain and swelling of her right leg. Her right lower limb was cold and right leg circumference was 8 cm more that the left one. Her vital parameters were in the normal range. Cardiovascular, respiratory and abdominal examination was normal. The patient had had a right hip fracture 35 days prior to presentation and was under conservative therapy at the time of presentation at our hospital. Colour Doppler ultrasound of the lower limb vessels revealed thrombosis in the right popliteal, superficial, deep and common femoral veins. Parenteral heparin and oral warfarin were started and coagulation tests were performed daily. Warfarin was initiated at a dose of 15 mg on the first day, 10 mg on the second day and 5 mg on the third day. On the third day, the international normalised ratio (INR) was in the normal range and parenteral heparin was discontinued. On the fifth day of warfarin therapy, the patient developed diffused, extremely painful, erythematous skin eruptions in the left lower limb. On the sixth day, the skin began to peel off and the condition progressed to an extensive lesion with severe skin necrosis of the left lower limb (Figure 1). Warfarin was discontinued and intravenous heparin was started. Vitamin K and fresh frozen plasma were also administered. Tests for factor V Leiden, lupus anticoagulant, anticardiolipin and antiphospholipid antibodies were negative. Surgical debridement of the necrotic area was performed and skin grafting was performed later. Finally, the patient was discharged after two months with a good general condition, on therapy with enoxaprin. * Corresponding author Email: dr.mahi1118@gmail.com 1 Department of Surgery, Vardhaman Mahavir Medical College and Safdarjung Hospital, New Delhi 110029, India Figure 1: Warfarin-induced extensive skin necrosis. De rm at ol og y
华法林引起的皮肤坏死:一种罕见但灾难性的华法林并发症
华法林引起的皮肤坏死是一种罕见但灾难性的华法林治疗并发症,患病率为0.01%至0.1%。本病例报告讨论一例华法林引起的皮肤坏死。病例报告我们报告一例肥胖,55岁女性,在华法林治疗的第五天出现左下肢大面积皮肤坏死,早期诊断和治疗效果良好。华法林引起的皮肤坏死是华法林产生的相对高凝状态的结果。华法林引起的皮肤坏死通常发生在肥胖,50岁左右的围绝经期妇女,高负荷剂量的华法林。华法林诱发的皮肤坏死通常累及有大量脂肪组织的皮肤和皮下组织,如乳房、腹部、大腿或臀部。它在开始治疗后的三到六天内出现。结论应重视华法林致皮肤坏死的及时预防和处理,防止永久性组织损伤。使用较低的初始剂量和逐渐增加的每日剂量的更渐进的方法被认为可以降低华法林引起的皮肤坏死的风险。华法林是医学实践中非常常用的抗凝血剂。华法林诱发的皮肤坏死(WISN)是一种罕见但灾难性的华法林治疗并发症,患病率为0.01%至0.1%1,2。在此,我们报告一位55岁女性WISN病例。病例报告一名55岁妇女因右腿疼痛和肿胀入院。右下肢冷,右腿周长比左腿长8厘米。她的生命参数在正常范围内。心血管、呼吸、腹部检查正常。患者在就诊前35天发生右髋骨折,在我院就诊时正在接受保守治疗。下肢血管彩超示右腘静脉、股浅静脉、股深静脉及股总静脉血栓形成。开始静脉注射肝素和口服华法林,每天进行凝血试验。华法林的起始剂量为第一天15mg,第二天10mg,第三天5mg。第3天,国际正常化比率(INR)在正常范围内,停用肝素。华法林治疗第5天,患者左下肢出现弥漫性、极痛、红斑性皮肤疹。第6天,皮肤开始脱落,病情发展为广泛病变,左下肢皮肤严重坏死(图1)。停用华法林,开始静脉注射肝素。同时给予维生素K和新鲜冷冻血浆。Leiden因子、狼疮抗凝血剂、抗心磷脂和抗磷脂抗体均为阴性。对坏死区域进行外科清创,随后进行植皮手术。两个月后患者出院,一般情况良好,接受依诺萨林治疗。*通讯作者Email: dr.mahi1118@gmail.com 1 Vardhaman Mahavir医学院和Safdarjung医院外科,新德里110029,印度图1:华法林引起大面积皮肤坏死。我很高兴见到你
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信